Boring_Bernie
31 Dec 2019
Provexis redprince: Okay so revenue up and losses reduced from same period last year. By-Health now doing x 9 separate studies with x 5 completed with “excellent results†reported in those completed. This is an increase in the number of studies originally and previously mentioned and represents a serious investment on their part. Interesting to say the least. Yea, two studies completed since last time they reported and two new ones added. The fact that two new ones are due to start next year suggests that ByHealth are still likely a way off getting Blue Hat status, so it’s good to see losses reducing. Trade payables and receivables aren’t as healthy as the corresponding numbers from 12 months ago, so, while the operating loss is much better, the cashflow is much the same as last FY FF+ continues to underwhelm, and AA revenue tends to be H1 dominated, so I’m not getting carried away,but, all in all, that’s a decent set of results
redprince
31 Dec 2019
Provexis Okay so revenue up and losses reduced from same period last year. By-Health now doing x 9 separate studies with x 5 completed with “excellent results†reported in those completed. This is an increase in the number of studies originally and previously mentioned and represents a serious investment on their part. Interesting to say the least.
Boring_Bernie
30 Dec 2019
Provexis redprince: Tomorrow is likely to be the usual cut and paste Well, yes, doubtless it will be, but the numbers will be different, with, hopefully an increase in revenue from the AA and an increased contribution from FF+ For the corresponding period last year these were 120k and 47k ( top line), with another 25k or so extra from DSM. If the first two numbers can be something like 140 to 150k and 60 to 75k respectively then we might end up with reduced losses, which, while we hope for concrete news from China is probably the best we can expect. BB
redprince
30 Dec 2019
Provexis Looks like news out tomorrow.They always issue on the last day and never have anything substantive to justify the wait. Tomorrow is likely to be the usual cut and paste.
nest_of_rampers
20 Dec 2019
Provexis Whoever posts 1st on Jan 1st , start a new thread this one is too long now.
nest_of_rampers
20 Dec 2019
Provexis Sp is pushing up against LT resistance from 2017 , maybe next week we will break through ? if so that is a buy signal IMO ( but maybe for a quick trade ? ) will know more when we see the size of the buys. I have kept my powder dry since my ave is about 1.65p, I am not convinced yet that this is a serious move up. [link]
Boring_Bernie
18 Dec 2019
Provexis nest_of_rampers: Who is Lucas ? Asset Match Asset Match I'm using Asset Match, the new way to trade private company shares. Find out more here: [link] He’s a mate of Hammer54 who, if you remember, used to post on here.
nest_of_rampers
18 Dec 2019
Provexis Who is Lucas ? just a HNW PI ? Does he just hang around the Pharma sector ?
nest_of_rampers
18 Dec 2019
Provexis If the SP ends the week above 0.575 it will be good IMO , lots of LT S&R there [link]
grandslam99
18 Dec 2019
Provexis With the Bid Price going as high as 0.7 p, the investors in the latest fund raising are already sitting on a 75% profit. We are bound to see some profit taking if the SP continues to rise - but let’s hope that we have started to turn the corner and that the latest rise is sustainable. The results to be announced shortly will tell us more about progress and sustainability.
redprince
18 Dec 2019
Provexis Nice to see our largest private shareholder buy more however as said before he is in at a relatively low entry point compared to most holders’ average here.Everything should be seen in its relative context. I am thinking the relatively modest fund raising has helped to encourage the recent round of buying.
nest_of_rampers
17 Dec 2019
Placing
nest_of_rampers
17 Dec 2019
Placing Anyone’s guess , there are some big holders that might want to reduce so maybe it’s them massaging the price up? will know more at the end of the week and see where the SP has stopped.
grandslam99
17 Dec 2019
Placing I guess that the big question is whether or not the up and coming results will substantiate the hype or will they knock it back again. Still no news from the Company - which is really poor in my opinion when there is so much going on with Bi Health, blue Cap status, new products, DSM Revenues, FF+ revenues etc etc.
